Cécile Guillemet

Prospective Multicentric Randomized Phase III Study of Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors Comparing Interruption Versus Continuation of Treatment Beyond 1 Year: The French Sarcoma Group

Jean‐Yves Blay, Axel Le Cesne, Isabelle Ray‐Coquard et al. · Journal of Clinical Oncology · 2007 · 390 citations

Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial

Olivier Mir, Thomas Brodowicz, Antoîne Italiano et al. · The Lancet Oncology · 2016 · 276 citations

Oncology, Metronomic Therapy, Clinical Trials +5

Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up

Nicolas Penel, Axel Le Cesne, B. Bui et al. · Annals of Oncology · 2010 · 229 citations · Full text

Medicine, Fnclcc/french Sarcoma Group, Pathology +5

Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France

Nicolas Penel, Jean‐Michel Coindre, Sylvie Bonvalot et al. · European Journal of Cancer · 2016 · 159 citations · Full text

Primary cardiac sarcomas: A retrospective study of the French Sarcoma Group

Nicolás Isambert, Isabelle Ray‐Coquard, Antoîne Italiano et al. · European Journal of Cancer · 2013 · 145 citations

Retrospective Study, Primary Cardiac Sarcomas, Cardiology +1